Authors: Quentin M. Anstee, Stuart McPherson, Kate Hallsworth and Laura Haigh
Release date: July 2022
This course was developed by UEG
Nonalcoholic fatty liver disease (NAFLD) is a highly prevalent but largely asymptomatic disease that poses a major challenge to healthcare systems worldwide. Disease severity and outcome vary considerably and those at greatest risk of progression from steatosis and steatohepatitis to cirrhosis and hepatocellular carcinoma need to be identified.
This online course, from the multidisciplinary team of Quentin M. Anstee, Stuart McPherson, Kate Hallsworth and Laura Haigh, provides a comprehensive update on all aspects of NAFLD. After introducing the epidemiology and natural history of NAFLD, the course turns its attention to biomarkers, patient identification and care pathways, dietary and lifestyle interventions, and pharmacotherapy.
The course includes detailed PPT slides and bespoke video presentations, which were filmed in May 2022. The estimated time needed to complete the course, including the final assessment, is 120 minutes.
Target audience
This course is designed for gastroenterologists and/or hepatologists in training, liver pathologists, endocrinologists/diabetologists, primary care physicians, nurses, allied health professionals, basic scientists working in translational biomedicine, and medical students.
